Physician profile

Luis Daniel Munoz

Internal Medicine · Riverside, CA

NPI 1790993467

$338.68

in general payments reported to CMS, 2019-2025

6 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$123.44

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $205.98 2019-2024 Assurity
Edwards Lifesciences Corporation $38.20 2019
Irhythm Technologies, INC. $34.23 2023 Zio Xt Patch
Boston Scientific Corporation $21.25 2024 Overstitch Nxt Endoscopic Suturing System
Lantheus Medical Imaging, INC. $21.19 2023 Definity
Novo Nordisk INC $17.83 2024 Ozempic, Rybelsus

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Luis Daniel Munoz

$338.68

in general payments reported 2019-2025

Years
2019-2024
Top company
Abbott Laboratories

https://glasscript.com/doctor/263408/luis-daniel-munoz

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.